| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Brown Vance R | SVP, GC and Corp. Secretary | 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH | /s/ Susan Thompson, Attorney-in-Fact | 02 Jul 2025 | 0001868243 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Common Stock | Options Exercise | $0 | +4,036 | +13% | $0.000000 | 35,403 | 01 Jul 2025 | Direct | F1 |
| transaction | BSX | Common Stock | Tax liability | $204,531 | -1,952 | -5.5% | $104.78 | 33,451 | 01 Jul 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Restricted Stock Units | Options Exercise | $0 | -4,036 | -100% | $0.000000 | 0 | 01 Jul 2025 | Common Stock | 4,036 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
| F2 | Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2022, the first anniversary of the date of grant. |